Hims & Hers Health (NYSE:HIMS) Shares Up 1.3% - What's Next?

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report)'s stock price was up 1.3% during mid-day trading on Wednesday . The stock traded as high as $46.52 and last traded at $43.53. Approximately 29,019,188 shares were traded during trading, an increase of 29% from the average daily volume of 22,466,174 shares. The stock had previously closed at $42.95.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on HIMS. UBS Group set a $30.00 price target on Hims & Hers Health in a report on Monday. Piper Sandler reiterated a "neutral" rating and set a $39.00 price objective (up previously from $35.00) on shares of Hims & Hers Health in a research report on Tuesday, May 6th. Truist Financial set a $45.00 target price on shares of Hims & Hers Health in a report on Tuesday. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Hims & Hers Health in a research note on Wednesday, May 7th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Hims & Hers Health in a report on Monday. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $38.31.

Hims & Hers Health Trading Up 12.0%

The firm's 50-day moving average price is $49.65 and its 200-day moving average price is $39.46. The stock has a market capitalization of $10.38 billion, a PE ratio of 67.20, a PEG ratio of 1.56 and a beta of 2.09.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last issued its quarterly earnings data on Monday, May 5th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.12 by $0.08. The business had revenue of $586.01 million for the quarter, compared to the consensus estimate of $535.21 million. Hims & Hers Health had a return on equity of 22.75% and a net margin of 9.24%. The company's quarterly revenue was up 110.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.05 earnings per share. On average, equities research analysts predict that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.

Insider Activity at Hims & Hers Health

In other news, CEO Andrew Dudum sold 36,460 shares of the stock in a transaction that occurred on Wednesday, April 16th. The stock was sold at an average price of $28.04, for a total value of $1,022,338.40. Following the sale, the chief executive officer now directly owns 92,103 shares in the company, valued at approximately $2,582,568.12. This represents a 28.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Soleil Boughton sold 3,236 shares of the firm's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $27.77, for a total value of $89,863.72. Following the sale, the insider now directly owns 170,285 shares of the company's stock, valued at $4,728,814.45. This represents a 1.86% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 706,454 shares of company stock worth $35,220,112. Company insiders own 13.71% of the company's stock.

Institutional Trading of Hims & Hers Health

A number of hedge funds and other institutional investors have recently bought and sold shares of HIMS. Smartleaf Asset Management LLC boosted its stake in shares of Hims & Hers Health by 15.7% during the first quarter. Smartleaf Asset Management LLC now owns 1,672 shares of the company's stock valued at $49,000 after purchasing an additional 227 shares during the period. Allworth Financial LP lifted its holdings in Hims & Hers Health by 20.0% during the 1st quarter. Allworth Financial LP now owns 2,006 shares of the company's stock valued at $56,000 after buying an additional 334 shares in the last quarter. Signaturefd LLC boosted its position in Hims & Hers Health by 17.7% in the 1st quarter. Signaturefd LLC now owns 2,586 shares of the company's stock valued at $76,000 after buying an additional 388 shares during the period. SlateStone Wealth LLC grew its stake in Hims & Hers Health by 4.0% in the 4th quarter. SlateStone Wealth LLC now owns 10,640 shares of the company's stock worth $257,000 after acquiring an additional 413 shares in the last quarter. Finally, Kilter Group LLC grew its stake in Hims & Hers Health by 1.0% in the 1st quarter. Kilter Group LLC now owns 43,989 shares of the company's stock worth $1,300,000 after acquiring an additional 450 shares in the last quarter. Hedge funds and other institutional investors own 63.52% of the company's stock.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.